Stephen Rosenthal, MD

Medical Director, Child and Adolescent Gender Center
Pediatric endocrinologist

Dr. Stephen M. Rosenthal is co-founder and medical director of the multi-disciplinary UCSF Child and Adolescent Gender Center, where he cares for transgender youth. He also cares for pediatric patients with endocrine disorders, such as abnormalities of growth and puberty and abnormalities of thyroid function. He previously served as program director for pediatric endocrinology and director of the pediatric endocrine clinics.

Rosenthal has conducted numerous multicenter clinical trials. He is currently one of four principal investigators for “The Impact of Early Medical Treatment in Transgender Youth,” a multi-center study sponsored by the National Institutes of Health and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. He has published many papers on the care of transgender youth in scholarly journals, such as Pediatrics and the Journal of Clinical Endocrinology & Metabolism.

Rosenthal earned his medical degree at Columbia University, where he also completed a residency in pediatrics. He then came to UCSF for a fellowship in pediatric endocrinology.

An active member of the Pediatric Endocrine Society, Rosenthal has served a term as president and on multiple committees. He is currently vice president, clinical scientist, of the international Endocrine Society, where he also has served on various committees. When the Endocrine Society created a task force to revise guidelines for clinical care of transgender patients, Rosenthal served as the Pediatric Endocrine Society's official representative and a co-author of the guidelines.

Clinics

Child and Adolescent Gender Center at San Mateo Pediatric Specialty Care Clinic
101 S. San Mateo Drive, Suite 205
San Mateo, CA 94401-3843
Phone: (650) 685-8419
Fax: (650) 685-8392

Child and Adolescent Gender Center Clinic
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 353-7337
Fax (Attn: Dr. Stephen Rosenthal): (415) 476-8214

Disorders of Sex
Development Clinic

1825 Fourth St., Fifth Floor, 5B
San Francisco, CA 94158
Phone: (415) 353-2200
Fax: (415) 353-2480

Endocrinology Clinic
1825 Fourth St., Sixth Floor
San Francisco, CA 94158
Phone: (415) 353-7337
Fax: (415) 476-8214

Conditions & Treatments

More about Stephen Rosenthal

Additional Languages

French

Education

Columbia University 1976

Residencies

Columbia University, Pediatrics 1979

Fellowships

UCSF Medical Center, Endocrinology 1982

Selected Research and Publications

  1. Vance SR, Rosenthal SM. A Closer Look at the Psychosocial Realities of LGBTQ Youth. Pediatrics. 2018 Apr 16.
  2. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG. ENDOCRINE TREATMENT OF GENDER-DYSPHORIC/GENDER-INCONGRUENT PERSONS: AN ENDOCRINE SOCIETY CLINICAL PRACTICE GUIDELINE. Endocr Pract. 2017 Dec; 23(12):1437.
  3. Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, Rosenthal SM, Safer JD, Tangpricha V, T'Sjoen GG. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2017 Nov 01; 102(11):3869-3903.
  4. Lopez X, Marinkovic M, Eimicke T, Rosenthal SM, Olshan JS. Statement on gender-affirmative approach to care from the pediatric endocrine society special interest group on transgender health. Curr Opin Pediatr. 2017 Aug; 29(4):475-480.
  5. Vance SR, Deutsch MB, Rosenthal SM, Buckelew SM. Enhancing Pediatric Trainees' and Students' Knowledge in Providing Care to Transgender Youth. J Adolesc Health. 2017 Apr; 60(4):425-430.
  6. Rosenthal SM. Transgender youth: current concepts. Ann Pediatr Endocrinol Metab. 2016 Dec; 21(4):185-192.
  7. Olson-Kennedy J, Cohen-Kettenis PT, Kreukels BP, Meyer-Bahlburg HF, Garofalo R, Meyer W, Rosenthal SM. Research priorities for gender nonconforming/transgender youth: gender identity development and biopsychosocial outcomes. Curr Opin Endocrinol Diabetes Obes. 2016 Apr; 23(2):172-9.
  8. Vance SR, Rosenthal SM. Treating Transgender Youth: Pushing the Dialogue Forward. J Adolesc Health. 2015 Oct; 57(4):357-8.
  9. Bonifacio HJ, Rosenthal SM. Gender Variance and Dysphoria in Children and Adolescents. Pediatr Clin North Am. 2015 Aug; 62(4):1001-16.
  10. Vance SR, Ehrensaft D, Rosenthal SM. Author's Response. Pediatrics. 2015 May; 135(5):e1366-7.
  11. Vance SR, Halpern-Felsher BL, Rosenthal SM. Health care providers' comfort with and barriers to care of transgender youth. J Adolesc Health. 2015 Feb; 56(2):251-3.
  12. Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Rosenthal SM, Shuster JJ, Zou B, Brusko TM, Hulme MA, Wasserfall CH, Mathews CE, Atkinson MA, Schatz DA. Anti-thymocyte globulin/G-CSF treatment preserves ß cell function in patients with established type 1 diabetes. J Clin Invest. 2015 Jan; 125(1):448-55.
  13. Rosenthal SM. Approach to the patient: transgender youth: endocrine considerations. J Clin Endocrinol Metab. 2014 Dec; 99(12):4379-89.
  14. Vance SR, Ehrensaft D, Rosenthal SM. Psychological and medical care of gender nonconforming youth. Pediatrics. 2014 Dec; 134(6):1184-92.
  15. Lazure P, Bartel RC, Biller BM, Molitch ME, Rosenthal SM, Ross JL, Bernsten BD, Hayes SM. Contextualized analysis of a needs assessment using the Theoretical Domains Framework: a case example in endocrinology. BMC Health Serv Res. 2014 Jul 24; 14:319.
  16. Herold KC, Gitelman SE, Willi SM, Gottlieb PA, Waldron-Lynch F, Devine L, Sherr J, Rosenthal SM, Adi S, Jalaludin MY, Michels AW, Dziura J, Bluestone JA. Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial. Diabetologia. 2013 Feb; 56(2):391-400.
  17. Sherer I, Rosenthal SM, Ehrensaft D, Baum J. Child and Adolescent Gender Center: a multidisciplinary collaboration to improve the lives of gender nonconforming children and teens. Pediatr Rev. 2012 Jun; 33(6):273-5.
  18. Cheung CC, Cadnapaphornchai MA, Ranadive SA, Gitelman SE, Rosenthal SM. Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor. Int J Pediatr Endocrinol. 2012 Feb 10; 2012(1):3.
  19. Ranadive SA, Rosenthal SM. Pediatric disorders of water balance. Pediatr Clin North Am. 2011 Oct; 58(5):1271-80, xi-xii.
  20. Aslan IR, Baca EA, Charlton RW, Rosenthal SM. Respiratory syncytial virus infection as a precipitant of thyroid storm in a previously undiagnosed case of graves' disease in a prepubertal girl. Int J Pediatr Endocrinol. 2011; 2011:138903.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.